Kate Pinner

Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study

Patricia Murphy, Margaret Moline, David Mayleben et al. · Journal of Clinical Sleep Medicine · 2017 · 323 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers

Annemiek Vermeeren, Stefan Jongen, Patricia Murphy et al. · SLEEP · 2018 · 227 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2

Mikko Kärppä, Jane Yardley, Kate Pinner et al. · SLEEP · 2020 · 165 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial

Jane Yardley, Mikko Kärppä, Yuichi Inoue et al. · Sleep Medicine · 2021 · 87 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials

Margaret Moline, Gary Zammit, Jane Yardley et al. · Postgraduate Medicine · 2020 · 51 citations

Medicine, Pharmacology, Pharmacotherapy +17